EUCODIS

Vienna, Austria Founded: 2007 • Age: 19 yrs Acquired By Biosynth
Drug research, enzyme identification, biocatalysis, and formulation services are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About EUCODIS

EUCODIS is a company based in Vienna (Austria) founded in 2007 was acquired by Biosynth in August 2022. EUCODIS operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.

  • Headquarter Vienna, Austria
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Biosynth

    (Aug 02, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of EUCODIS

Premium access

Detailed funding history for EUCODIS

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in EUCODIS

EUCODIS has secured backing from 1 investor. Prominent investors backing the company include Biosynth.

All
Investor Description Founded Year Domain Location
Biosynth is engaged in supplying critical raw materials and services for life sciences and diagnostics.
Locked Locked Locked
Premium access

Investor details for EUCODIS

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by EUCODIS

Investments
Premium access

Investment portfolio details for EUCODIS

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - EUCODIS

Premium access

Detailed financials for EUCODIS

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Eucodis Comparisons

EUCODIS Primary company
Description
Drug research, enzyme identification, biocatalysis, and form...
Location
Vienna, Austria
Founded Year
2007
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for EUCODIS

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of EUCODIS

EUCODIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug discovery and development services for small molecules are provided.
Locked Locked Locked
CDMO services for pharma, biotech, and specialty ingredients are provided.
Locked Locked Locked
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Generic drugs and clinical research services are provided globally.
Locked Locked Locked
Laboratory testing, clinical trial research, and biopharma services are provided.
Locked Locked Locked
AI powered scientific data management and workflow automation solutions
Premium access

Detailed competitors of EUCODIS

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Eucodis

Premium access

Complete news archive for EUCODIS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EUCODIS

EUCODIS was founded in 2007.

EUCODIS is headquartered in Vienna, Austria.

Jan Modregger is the current CEO of EUCODIS.

Critical raw materials and services supplier for pharma, vaccines, and diagnostics. It supplies a wide array of chemical and biochemical products, focusing on small molecules, peptides, and key biological raw materials. The company offers comprehensive services supporting life science research and development, including custom synthesis and manufacturing. Its expertise spans complex chemistry, biocatalysis, bioconjugates, peptide discovery and production, and biologics for diagnostics. Manufacturing capabilities range from milligram to multi-ton scales, adhering to ISO 9001 and GMP standards. The company serves pharmaceutical, life science, and diagnostic sectors, as well as food, agrochemical, and cosmetic industries.

EUCODIS's top competitors include Pharmaron, Pfizer and Lonza.

EUCODIS has 1 investor. Key investors include Biosynth.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available